ophthalmic lenses

Search documents
EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials
Globenewswire· 2025-07-21 06:00
Core Insights - EssilorLuxottica has signed an agreement to acquire PUcore's division focused on the development, manufacturing, and sale of ophthalmic lens materials, enhancing its R&D and production capabilities for innovative high index lenses [1][2] - The acquisition includes a research and development unit, a materials production facility, and a sales office in South Korea, along with an intellectual property portfolio related to product formulations and production processes [2][3] - The transaction is expected to close by the end of 2025, pending regulatory approvals and customary closing conditions [4] Company Strategy - The acquisition aligns with EssilorLuxottica's commitment to improving standards in the research, development, and manufacturing of ophthalmic lenses, allowing the company to expand its portfolio of patents, technologies, and expertise [3] - By enhancing the production and formulation of high index monomers, the company aims to improve performance and sustainability across the ophthalmic industry [3]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025
Globenewswire· 2025-07-09 16:00
Summary of Key Points Core Viewpoint - As of June 30, 2025, EssilorLuxottica has disclosed its share capital and voting rights, highlighting its position as a global leader in the ophthalmic lens, frame, and sunglasses market [2]. Group 1: Share Capital and Voting Rights - The total number of shares outstanding for EssilorLuxottica is 463,145,529 [3]. - The number of real voting rights, excluding treasury shares, is 461,150,585 [3]. - The theoretical number of voting rights, including treasury shares, remains at 463,145,529 [3]. - Voting rights for any shareholder are capped at 31%, as per the company's by-laws [3].
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2025
Globenewswire· 2025-06-12 16:00
Summary of Key Points Core Viewpoint - As of May 31, 2025, EssilorLuxottica, a global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, disclosed its outstanding shares and voting rights [2]. Group 1: Share Capital and Voting Rights - Total shares outstanding amount to 457,507,201 [3]. - The number of real voting rights, excluding treasury shares, is 455,511,025 [3]. - The theoretical number of voting rights, including treasury shares, remains at 457,507,201 [3]. - Voting rights are capped at 31% for any shareholder, as per the company's by-laws [3].